Pfizer R&D Changes: Corr Succeeds Niblack, R&D Integrated With Marketing
Executive Summary
Pfizer is building a formal reporting structure between drug development and marketing as part of an R&D management transition in anticipation of the retirement of Global R&D President John Niblack, PhD
You may also be interested in...
Pfizer Names LaMattina To Head R&D; Licensing Is “Corr” Function
Pfizer Global R&D President John LaMattina, PhD, will attempt to enhance the productivity of the largest pharmaceutical research operation in the world
Pfizer Names LaMattina To Head R&D; Licensing Is “Corr” Function
Pfizer Global R&D President John LaMattina, PhD, will attempt to enhance the productivity of the largest pharmaceutical research operation in the world
Merck Completes R&D Leadership Transition To Kim; Spotlight On Genomics
Merck's effort in genomics will take on a new focus under new R&D head Peter Kim, PhD